Blockchain Could Strengthen Security and Traceability in Genomic Data Management
Secure Data Infrastructure Is Becoming More Important as Genomic Databases Expand
Genomic sequencing is generating enormous volumes of sensitive biological information. As healthcare organizations, research institutions and biotechnology companies increasingly share genomic datasets, secure systems for managing access, ownership and data integrity are becoming increasingly important.
The blockchain in genomic data management market was valued at approximately USD 294.5 million in 2024 and is projected to reach USD 19.83 billion by 2035, representing a CAGR of 43.8%.
Blockchain technology can provide decentralized records that make transactions and data access easier to trace. In genomic research, this could support controlled sharing of information while maintaining a record of how data are accessed or transferred.
Privacy is particularly important because genomic information can potentially reveal sensitive information about individuals and families. Secure data-sharing frameworks could therefore support collaboration without requiring organizations to rely entirely on centralized databases.
Blockchain may also support data ownership and consent management. Individuals could potentially have greater visibility into how their genomic information is used in research or commercial applications.
The technology is still emerging, and challenges include scalability, interoperability, regulatory compliance and integration with existing healthcare information systems.
As sequencing becomes more accessible, the need for secure infrastructure is likely to increase. Blockchain may become one component of broader genomic data-management systems alongside encryption, cloud computing and advanced access controls.
For more information on the Blockchain in Genomic Data Management Market, visit:
Comments